In the vivo experiments, we utilised 6‐ to 8‐week‐old female C57BL/6 mice to establish subcutaneous xenograft models with MEC25 cells, aiming to further investigate the impact of MECP2 on the growth of ESCC cells. Here, MECP2 is linked to esophageal squamous cell carcinoma.